Biocair Opens New Site in Beijing
Biocair has continued its global expansion by opening an office in Beijing, China. The state of the art office facility situated in the Yizhuang Economic and Technological Development Zone will strengthen Biocair’s presence in China and Asia as a whole. The office will accommodate 4 staff members and be equipped with qualified and validated cold chain equipment and storage.
The office is strategically situated with excellent transport links within Beijing and the international airport.
Kevin Xu, Biocair’s General Manager in China, commented “The successful setup of the Beijing office enables Biocair to expand its shipping network in China and provide its excellent service to clients in the north of the country”.
Scotland has outstanding logistics, cold chain and packaging capabilities to enable the time-critical shipment of cells and biological products, as well as medical technologies, into and out of the country – so it’s no wonder that we’re responsible for 60% of Europe’s biosafety testing.
Biocair is a specialist logistics provider to the pharmaceutical and biotech industries based in Edinburgh. Don Riach, strategic development director for Biocair, explains the logistics behind the clinical trial services in Scotland.
"Approximately 50,000 trial samples are sent every month from hospitals and clinics all over Europe, Middle East and Northern Africa for blood and urine analysis in Scotland. However, to retain sample integrity, the ambient blood samples must reach the central Scotland facility within 48 hours of collection.
"Specialist couriers like us provide bespoke logistics, ensuring time-critical delivery for high-value or irreplaceable samples in dedicated packaging often at controlled temperatures. Around 2,000 of these inbound blood samples per month are shipped by these specialist couriers to this central laboratory in Scotland, with an on-time performance of over 99%.
"In addition, Scotland’s good choice of airlines and routes available from Edinburgh and Glasgow help us achieve 48 hour deliveries outbound to worldwide destinations.
"Lufthansa and KLM fly to Frankfurt and Amsterdam, connecting Edinburgh to hundreds of international destinations around the world. A number of other international airlines, including Qatar Airways, Turkish Airlines, Emirates, United and US Airways, also operate from Scottish airports, connecting Scotland to the Middle East, Africa, Asia, Austrailasia and the Americas.
"In addition to arranging door-to-door inbound movements, we export biological samples, research compounds, active pharmaceutical ingredients and clinical trial research medicines worldwide on behalf of a clinical supplies company. These are sent in validated temperature controlled packaging that is in line with regulatory authority quality guidelines."
Scotland can support the logistics required for your biopharmaceutical and stem cell products - find out more about how we can help you.
Article written for Scottish Development International
CAMBRIDGE, UK – 29th October 2014 – Biocair International, the world’s leading provider of logistics and supply chain services to the life sciences industry, announced today that it is moving into a new 16,000 sq ft corporate headquarters on 17th November 2014. The office, located south of the city of Cambridge, UK, provides customer services, operations, sales and temperature-controlled packaging solutions. The new premises will further enhance Biocair’s high level of expert service provided to its customers across Europe. The office benefits from a wide portfolio of temperature-controlled packaging solutions, dry ice storage, and latest-generation high-capacity Foster Eco Pro G2 refrigerator and freezer rooms, with 24/7 temperature monitoring. Collections and deliveries will continue to be via Biocair’s proprietary temperature-controlled vehicles.
Simon Higgs, Chairman of Biocair, stated: “I am delighted to announce this move into our new state-of-the-art office and warehouse facility. Biocair’s newly expanded headquarters will continue to support our UK customer base but now serves as our regional European Centre of Excellence to support our continuing growth across the life science sectors throughout Europe.”
Biocair provides logistics services and support to a wide variety of organizations, from large multi-national pharmaceuticals, global central laboratories and clinical manufacturing organisations supplying the clinical trial arena to niche biotechs and individual R&D scientists across the globe. By focusing on the precise needs of these demanding sectors and utilising our extensive understanding of the research process and science industry, we have developed our range of services to ease the process of discovery and aid the development of leading-edge, novel therapies.
“Our facility supports the increasing demand for logistics and cool chain services across the UK and Europe, ranging from R&D products and biological clinical trial samples to larger IMP and drug moves. We have strategically located offices around the world advising on current classification and regulatory requirements, applying precise procedures and packaging while supplying the correct documentation to fulfil all legal requirements,” said Vincent Howard, Managing Director. “Further new facilities and enhanced infrastructure across the globe are already scheduled for 2015,” concluded Mr Howard.
Biocair is a global specialist logistics provider dedicated to the pharmaceutical and life science sectors. Our standing in the market was enhanced following acquisition in 2012 by IBC Inc. This has provided depth to our global footprint and added a further layer of service, including a proprietary network and in-house brokerage. We have expanded into key locations across the globe, with Regional Centres of Excellence in Cambridge and Edinburgh (UK); Boston, New York, Philadelphia, Raleigh, Los Angeles, San Diego, San Francisco and Miami in the USA; Shanghai and Beijing in China; Singapore and Osaka in Japan. We support each of our offices with a network of carefully selected and managed service partners, many of whom we have worked with for more than 15 years, coupled with our proprietary network. This structure has enabled us to deliver highly flexible, market-leading and competitive service solutions to our customers across the globe for the last 27 years.
HOWARD Group is very pleased to announce that Biocair, the Cambridge-based global logistics specialist dedicated to the pharmaceutical, biotech and life science industries, is taking 11,500 sq ft of grade A office space at Iconix Park, Sawston.
The healthcare experts have taken three quarters of the available space at Iconix 1, a two-storey, high-specification contemporary building located close to the M11 to the South of Cambridge. In addition, Biocair has also taken a warehouse unit of 4,500 sq ft on the adjacent trade park.
Acquired by Howard Group in late 2013, Iconix Park consists of buildings 1,2 and 3. It is now an established Cambridge business location in the heart of the Cambridge Science and Technology Cluster. The park represents an exciting opportunity to build on the existing opportunity to build on the existing bio-medical and laboratory presence both in Sawston and the other south Cambridge locations.
Howard Group has planning consent already granted for a further 3.5 acre expansion of the estate to provide a total of over 100,000 sq ft of high specification office, R & D and laboratory facilities to complement their existing investment. The Group also owns and manages the adjacent trade park which consists of warehousing and trade counter units.
Colin Brown, development manager at Howard Group commented: “South Cambridge is fast becoming one of the most attractive locations in Europe for life science businesses due to the surrounding infrastructure, network of like-minded businesses and the availability of skilled labour. Iconix Park lies in the heart of a thriving concentration of organisations such as the Addenbrookes Biomedical Campus, Babraham Research Campus, the Wellcome Trust Genome Campus and many others. We expect shortly to be able to release news of further occupiers for the Park to join Xention and Biocair and look forward to the next phase of this exciting development of the estate.”